Thursday, 5 November 2026European Markets

WALLENIUS WILHELMS, HYDRATEC, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(vianews) - wallenius wilhelms (wawi.ol) is among this list of stock assets with the highest dividend rate and return on equity on the industrials sector.

financial asset price forward dividend yield return on equity
wallenius wilhelms (wawi.ol) kr73.50 12.91% 23.98%
hydratec (hydra.as) €86.00 6.9% 19.49%
sogeclair (sog.pa) €18.20 5% 4.24%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. wallenius wilhelms (wawi.ol)

12.91% forward dividend yield and 23.98% return on equity

wallenius wilhelmsen asa, together with its subsidiaries, transports and handle cars, tractors, trains, and windmills. it operates through three segments: shipping services, logistics services, and government services. the company provides liner services through a fleet of modern and versatile roro vessels, which carry a mix of products, such as auto, construction, mining, agriculture machinery, and breakbulk products. in addition, it offers inland transportation services, as well as operates vehicle and equipment processing centres and inland distribution networks. the company serves agriculture, automotive, aviation, boats and yachts, breakbulk, commercial vehicles, construction, machinery and machine tools, mining, oil and gas, power and energy, and rail industries. it operates approximately 125 vessels servicing 15 trade routes. the company was founded in 1861 and is based in lysaker, norway.

earnings per share

as for profitability, wallenius wilhelms has a trailing twelve months eps of kr17.17.

pe ratio

wallenius wilhelms has a trailing twelve months price to earnings ratio of 4.28. meaning, the purchaser of the share is investing kr4.28 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.98%.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on nov 9, 2023, the estimated forward annual dividend rate is 8.91 and the estimated forward annual dividend yield is 12.91%.

revenue growth

year-on-year quarterly revenue growth grew by 9.2%, now sitting on 5.15b for the twelve trailing months.

more news about wallenius wilhelms.

2. hydratec (hydra.as)

6.9% forward dividend yield and 19.49% return on equity

hydratec industries nv, through its subsidiaries, engages in the manufacture and sale of industrial systems and plastic components for food, health, and mobility markets in the netherlands, rest of europe, asia, north america, south america, africa, and oceania. it develops and produces sterilized product handling systems; and automated packaging solutions, including packaging for sterilized food in pouches, tins, and jars, as well as main-meal salads and agri-food in bags, nets, boxes, and crates. the company also supplies industrial incubators to produce day-old chicks; hatchery automation systems for processing of hatchery eggs and day-old chicks; climate control equipment for air and water treatment; hatchery management software for monitoring, analyzing, and optimizing the hatching process; and service and support for hatchery systems operation. in addition, it manufactures extrusion machines for pvc, pvc-o, and po pipes; plastic injection molding products for use in climate control systems, lorries, bicycle parts, and coffee machines; rubber and plastic precision components for fuel systems, braking and drive systems, dosing systems for beer, coffee and milk, medical cartridges, point-of-care instruments, and diagnosis equipment. hydratec industries nv is headquartered in amersfoort, the netherlands.

earnings per share

as for profitability, hydratec has a trailing twelve months eps of €12.29.

pe ratio

hydratec has a trailing twelve months price to earnings ratio of 7. meaning, the purchaser of the share is investing €7 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.49%.

more news about hydratec.

3. sogeclair (sog.pa)

5% forward dividend yield and 4.24% return on equity

sogeclair sa provides engineering and production services to the aeronautics, space, civil and military transport in france. it operates through three divisions: aerospace, vehicle, and simulation. the aerospace division engages in the provision of engineering services in aerostructures, cabins, systems, and manufacturing engineering and tooling services; and design and manufacture of complex structural thermoplastic products, additive manufacturing, and cockpit equipment, as well as cabin furniture and mechanism. the vehicle division is involved in the design and production of special civilian and military vehicles, as well as terrestrial drones, multi-mission platforms, and adapting vehicles. the simulation division engages in the design and supply of turnkey simulators; and development of software simulation platforms. sogeclair sa was incorporated in 1986 and is headquartered in blagnac, france.

earnings per share

as for profitability, sogeclair has a trailing twelve months eps of €0.65.

pe ratio

sogeclair has a trailing twelve months price to earnings ratio of 28. meaning, the purchaser of the share is investing €28 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.24%.

dividend yield

according to morningstar, inc., the next dividend payment is on may 15, 2023, the estimated forward annual dividend rate is 0.9 and the estimated forward annual dividend yield is 5%.

more news about sogeclair.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com